Hepatic drug metabolism and immunostimulation

Toxicology

Volumn 142, Issue 3, 2000, Pages 173-178

  Renton, Kenneth W ^a  

^a D   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450;

ARTICLE; DRUG ELIMINATION; DRUG METABOLISM; DRUG TRANSFORMATION; ENCEPHALITIS; GENE EXPRESSION; HUMAN; IMMUNOSTIMULATION; INFLAMMATION; PRIORITY JOURNAL;

EID: 0033989634     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(99)00142-0     Document Type: Article

References (67)

1. Abdel-Razzak Z., Corcos L., Fautrel A., Campion J.-P., Guillouzo A. Transforming growth factor-β1 down-regulates basal and polycyclic aromatic hydrocarbon-induced cytochromes P-450 1A1 and 1A2 in adult human hepatocytes in primary culture. Mol. Pharmacol. 46:1994;1100-1110.
2. Abdel-Razzak Z., Corcos L., Fautrel A., Guillouzo A. Interleukin-1β antagonizes phenobarbital induction of several major cytochromes P450 in adult rat hepatocytes in primary culture. FEBS Lett. 366:1995;159-164.
3. Anandatheerthavarada H.K., Williams J.F., Wecker L. The chronic administration of nicotine induces cytochrome P450 in rat brain. J. Neurochem. 60:1993;1941-1944.
4. Anari M.R., Renton K.W. Modulatory effect of hyperthermia on hepatic microsomal cytochrome P450 in mice. Biochem. Pharmacol. 46:1993;307-310.
5. Arvin B., Neville L.F., Barone F.C., Feurstein G.Z. Brain injury and inflammation, A putative role for TNF-alpha. Ann. N.Y. Acad. Sci. 116:1995;62-71.
6. Barker C.W., Fagan J.B., Pasco D.S. Interleukin-1 beta suppresses the induction of P4501A1 and P4501A2 mRNAs in isolated hepatocytes. J. Biol. Chem. 267:1992;8050-8055.
7. Bergh A.F., Strobel H.W. Reconstitution of the brain mixed function oxidase system: purlfication of NADPH-cytochrome P450 reductase and partial purlfication of cytochrome P450 from whole rat brain. J. Neurochem. 59:1992;575-581.
8. Carlson T.J., Billings R.E. Role of nitric oxide in the cytokine-mediated regulation of cytochrome P-450. Mol. Pharmacol. 49:1996;796-801.
9. Chang K.C., Lauer B.A., Bell T.D., Chai H. Altered theophylline pharmacokinetics during acute rispiratory viral illness. Lancet. 1:1978;1132-1133.
10. Clark M.A., Bing B.A., Gottschall P.E., Williams J.F. Differential effect of cytokines on the phenobarbital or 3-methylcholanthrene induction of P450 mediated monooxygenase activity in cultured rat hepatocytes. Biochem. Pharmacol. 49(1):1995;97-104.
11. Clarke C.J., Boyd G. Theophylline pharmacokinetics during respiratory viral infection. Lancet. 1:1979;492.
12. Craig P.I., Mehta I., Murray M., McDonald D., Astrom A., van der Meide P.H., Farrell G.C. Interferon down regulates the male-specific cytochrome P450IIIA2 in rat liver. Mol. Pharmacol. 38(3):1990;313-318.
13. Cribb A.E., Renton K.W. Dissociation of xanthine oxidase induction and cytochrome P450 depression during interferon induction in the rat. Biochem. Pharmacol. 46(11):1993;2114-2117.
14. Cribb A.K., Delaporte E., Kim S.G., Novak R.F., Renton K.W. Regulation of cytochrome P-4501A and cytochrome P-4502E induction in the rat. J. Pharmacol. Exp. Ther. 268:1994a;487-494.
15. Cribb A.K., Delaporte E., Kim S.G., Novak R.F., Renton K.W. Regulation of cytochrome P-4501A and cytochrome P-4502E induction in the rat during the production of interferon alpha/beta. J. Pharmacol. Exp. Ther. 268:1994b;487-494.
16. Delaporte E., Renton K.W. Cytochrome p4501al and cytochrome P4501A2 are downregulated at both transcriptional and post-transcriptional levels by conditions resulting in interferon-alpha/beta induction. Life Sci. 60:1997;787-796.
17. Delaporte E., Cribb A.E., Renton K.W. Modulation of rat hepatic CYP3A1 induction by the interferon inducer polyinosinic acid-polycytidylic acid (polyic). Drug Metab. Dispos. 21(3):1993;520-523.
18. Donato M.T., Guillen M.I., Jover R., Castell J.V., Gomez-Lechon M.J. Nitric oxide-mediated inhibition of cytochrome P450 by interferon-gamma in human hepatocytes. J. Pharmacol. Exp. Ther. 281:1997;484-490.
19. Eichizen H., Ohta Y., Shirataki H., Tsukamoto U., Umeda N., Ishizaki T.J. Effects of subchronic treatment with natural human interferons on antipyrine clearance and liver function in patients with chronic hepatitis. Clin. Pharmacol. 30:1990;562-567.
20. Fleetham J.A., Nakatsu K., Munt P.W. Theophylline pharmacokinteics and respiratory infections. Lancet. 2:1978;898.
21. Forsyth J.S., Moreland T.A., Ryelance G.W. The effect of fever on antipyrine metabolism in children. Br. J. Clin. Pharmacol. 13:1982;811-815.
22. Fukada Y., Sassa S. Supression of cytochrome P-4501A1 by interleukin-6 in humanhepaG2 hepatoma cells. Biochem. Pharmacol. 47:1994;1187-1195.
23. Fukuda Y., Ishida N., Noguchi T., Kappas A., Sassa S. Interleukin-6 down regulates the expression of transcripts encoding cytochrome P450 1A1, 1A2 and III3A in human hepatoma cells. Biochem. Biophys. Res. Commun. 184:1992;960-965.
24. Ghezzi P., Biancha M., Mantovani A., Spreafico F., Salmona M. Enhanced xanthine oxidase activity in mice treated with interferon and interferon inducers. Biochem. Biophys. Res. Commun. 119:1984;144-149.
25. Ghezzi P., Biancha M., Gianara L., Landolfi S., Salmona M. Role of reactive oxygen intermediates in the interferon mediated depression of hepatic drug metabolism amd protective effect of N-acetylcysteine in mice. Cancer Res. 45:1985;3444-3447.
26. Greenwald M., Koren G. Viral induced changes in theophylline handling in children. Am. J. Asthma Allergy Pediatr. 3:1990;162.
27. Hodgson P.D., Renton K.W. The role of nitric oxide generation in interferon evoked cytochrome P450 down-regulation. Int. J. Immunopharmacol. 17:1995;995-1000.
28. Jonkman J.H.G., Nicholson K.G., Farrow P.R. Effects of interferon on theophylline pharmacokinetics and metabolism. Br. J. Clin. Pharmacol. 27:1989;795-802.
29. Kawashima H., Strobel H.W. cDNA cloning of a novel rat brain cytochrome P450 belonging to the CYP2d subfamily. Biochem. Biophys. Res. Commun. 209:1995;535-540.
30. Kempermann G., Knoth R., Gebicke-Haerter P.J., Stolz B.-J., yolk B. Cytochrome P450 in rat astrocytes in vivo and in vitro: Intracellular localization and induction by phenytoin. J. Neurosci. Res. 39:1994;576-588.
31. Khatsenko O., Kikkawa Y. Nitric oxide differentially affects constitutive cytochrome P450 isoforms in rat liver. J. Pharmacol. Exp. Ther. 280:1997;1463-1470.
32. Khatsenko O.G., Barteneva N.S., De la Maza L.M., Kikkawa Y. Role of nitric oxide in the inhibition of cytochrome P450 in the liver of mice infected with Chlamydia trachomatis. Biochem. Pharmacol. 55:1998;1835-1842.
33. Khatsenko O.G., Gross S.S., Rifkind A.B., Vane J.R. Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc. Natl. Acad. Sci. USA. 90:1993;11147-11151.
34. Koren G., Greenwald M. Decrease in theophylline clearance causing toxicity during viral epidemics. J. Asthma. 22:1985;75-79.
35. Kraemer M.J., Furukawa C., Koup J.P., Shapiro G. Altered theophylline clearance during an influenza outbreak. Pediatrics. 69:1982;476-480.
36. Lee B.L., Wong D., Benowitz N.L., Sullam P.M. Altered patterns of drug metabolism in patients with aquired immunodeficiency syndrome. Clin. Pharmacol. Ther. 53:1993;529-535.
37. Leeson G.A., Biedenback S.A., Chan K.Y., Gibson J.P., Wright G.J. Decrease in activity of the drug metabolizing enzymes of the rat following the administration of tilorone hydrochloride. Drug. Metabolism Dispos. 4:1976;232-238.
38. Mannering G.J., Deloria L.B. The pharmacology and toxicology of interferons. An overview. Annu. Rev. Pharmacol. 26:1986;455-515.
39. Mannering G.J., Deloria L.B., Abbot V. Role of xanthine oxidase in the interferon mediated depression of cytochrome P450 system in mice. Cancer Res. 48:1988;2107-2112.
40. Morgan E.T., Norman C.A. Pretranslational suppression of cytochrome P-450h (IIC11) gene expression in. Drug Metab. Dispos. Biol. Fate Chem. 18:1990;649-653.
41. Morgan E.T. Suppression of P450IIC12 gene expression and elevation of actin messenger ribonucleic acid levels in the livers of female rats after injection of the interferon inducer poly rI.poly rC. Biochem. Pharmacol. 42(1):1991a;51-57.
42. Morgan E.T. Suppression of P450IIC12 gene expression and elevation of actin messenger. Biochem. Pharmacol. 42:1991b;51-57.
43. Norris P.J., Hardwick J.P., Emson P.C. Localization of NADPH cytochrome P450 oxidoreductase in rat brain by immunohistochemistry and in situ hybridization and a comparison with the distribution of neuronal NADPH diaphorase staining. Neuroscience. 61:1994;331-350.
44. Okuno H., Shiozaki Y., Kiato Y., Kuneida K., Seki T., Sameshima Y. Depression of drug metabololizing activity in human liver by interferon-a. Eur. J. Clin. Pharmacol. 39:1990;365-367.
45. Perry V.H., Andersson B., Gordon S. Macrophages and inflammation in the central nervous system. Trends Neurosci. 16:1993;268-273.
46. Ravindranath V., Boyd M.R. Xenobiotic metabolism in brain. Drug Metab. Rev. 27:1995;419-448.
47. Renton K.W. Altered theophylline kinetics. Lancet. 2:1978;160-1612.
48. Renton K.W. Depression of hepatic cytochrome P-450-dependent mixed function oxidases during infection with encephalomyocarditis virus. Biochem. Pharmacol. 30:1981;2333-2336.
49. Renton K.W. Relationships between the enzymes of detoxication and host defence mechanisms. Caldwell J., Jacoby W.B. Biological Basis of Detoxication. 1983;307-324 Academic Press, New York.
50. Renton K.W., Knickle L.C. Regulation of hepatic cytochrome P-450 during infectious disease. Can. J. Physiol. Pharmacol. 68:1990;777-781.
51. Renton K.W., Mannering G.J. Depression of the hepatic cytochrome P-450 mono-oxygenase system by administered tilorone (2,7-bis(2(diethylamino)ethoxy)fluoren-9-one dihydrochloride). Drug. Metab. Dispos. 4:1976;223-231.
52. Rothwell N.J., Luheshi G., Toulland S. Cytokines and their receptors in the central nervous system: Physiology, pharmacology and pathology. Pharmacol. Ther. 69:1996;85-95.
53. Sakai H., Okamoto T., Kikkawa Y. Suppression of hepatic drug metabolism by the interferon inducer, polyriboinosinic acid:polyribocitidylic acid. J. Pharmacol. Exp. Ther. 263:1992;381-386.
54. Sanne J.L., Krueger K.E. Expression of cytochrome P450 side-chain cleavage enzyme and 3 beta-hydroxysteroid dehydrogenase in the rat central nervous system: a study by polymerase chain reaction and in situ hybridization. J. Neurochem. 65:1995;528-536.
55. Sewer M.B., Morgan E.T. Nitric oxide-independent suppression of P450 2C 11 expression by interleukin-1beta and endotoxin in primary rat hepatocytes. Biochem. Pharmacol. 54:1997;729-737.
56. Stanley L.A., Adams D.J., Balkwill F.R., Griffin D., Wolf C.R. Differential effects of recombinant interferon alpha on constitutive and inducible cytochrome P450 isozymes in mouse liver. Biochem. Pharmacol. 42:1991;311-320.
57. Strobel, H.W., Kawashima, H., Geng, J., Sequeira, D., Bergh, A., Hodgson, A.V., Wang, H., Shen, S., 1995. Expression of multiple forms of brain cytochrome P450, Toxicol. Lett., 82-83, 639-643.
58. Tinberg N., Ingelman-Sundberg M. Expression, catalytic activity, and inducibility of cytochrome P450 2E1 (CYP2E1) in the rat central nervous system. J. Neurochem. 67(5):1996;2066-2073.
59. Tindberg N., Baldwin H.A., Cross A.J., Ingelman-Sundberg M. Induction of cytochrome P450 2E1 expression in rat and gerbil astrocytes by inflammatory factors and ischemic injury. Mol. Pharmacol. 50:1996;1065-1072.
60. Tinel M., Robin M.A., Doostzadeh J., Maratrat M., Ballet F., Fardel N., el K.J., Beaune P., Daujat M., Labbe G. et al. The interleukin-2 receptor down-regulates the expression of cytochrome P450 in cultured rat hepatocytes. Gastroenterology. 109:1995;1589-1599.
61. Volk, B., Meyer, R.P., von, L.F., Ibach, B., Knoth, R., 1995. Localization and characterization of cytochrome P450 in the brain. In vivo and in vitro investigations on phenytoin- and phenobarbital-inducible isoforms, Toxicol. Lett., 82-83, 655-662.
62. Warner M., Stromstedt M., Wyss A., Gustafsson J.A. Regulation of cytochrome P450 in the central nervous system. J. Steroid Biochem. Mol. Biol. 47:1993;191-194.
63. Williams S.J., Farrell G.C. Inhibition of antipyrine metabolism by interferon. Br. J. Clin. Pharmacol. 22:1986;610-612.
64. Williams S.J., Baird-Lambert J.A., Farrell G.C. Inhibition of theophylline metabolism by interferon. Lancet. 2:1987;939-941.
65. Wink D.A., Osawa Y., Darbyshire J.F., Jones C., Eshenaur S.C., Nims R.W. Arch. Biochem. Biophys. 300:1993;115-123.
66. Wright K., Morgan E.T. Transcriptional and post-transcriptional supression of P450IIC 11 and P450IIC 12 by inflammation. FEBS Lett. 271:1990;59-61.
67. Wyss A., Gustafsson J.-P., Warner M. Cytochromes P450 of the 2D subfamily in rat brain. Mol. Pharmacol. 47:1995;1148-1155.